Progress and challenges in seasonal influenza vaccination across 54 countries and areas in the WHO European Region, 2008/09-2022/23: a repeated cross-sectional ecological study

2008/09-2022/23年世卫组织欧洲区域54个国家和地区季节性流感疫苗接种的进展与挑战:一项重复横断面生态学研究

阅读:4

Abstract

BACKGROUND: Seasonal influenza causes up to 5 million severe cases and 650,000 deaths annually. Vaccination is recommended for high-risk groups and health workers, yet uptake remains low globally. This paper analyses the evolution of seasonal influenza vaccination programmes in the WHO European Region's 54 countries and areas (CA) from 2008/09 to 2022/23 to guide future policy and investment. METHODS: We conducted a descriptive, repeated cross-sectional ecological study using national data reported through WHO-UNICEF's Joint Reporting Form on Immunization and reports published by the European Centre for Disease Prevention and Control to analyse influenza vaccine doses, vaccine types, recommendations, coverage, and payment schemes. Trends in doses distributed per capita and older-adult vaccination coverage over 15 seasons were assessed across World Bank income groups. FINDINGS: Since 2008/09, the number of influenza vaccine doses distributed has doubled, driven mainly by increases in upper- (3-fold) and lower-middle-income (8-fold) CA. Yet, by 2022/23, dose availability per 1000 population remained substantially greater in high-income than lower-middle-income settings (145.7 versus 38.5). Recommendations expanded over time to additional target populations, but coverage monitoring remains limited, with fewer than 50% of CA reporting data for key groups, such as health workers. In 2022/23, median coverage among older adults was 55%, and only four CA met the World Health Assembly 75% coverage target. INTERPRETATION: Considerable progress has been made in influenza vaccination across the WHO European Region, with an increasing number of CA recommending vaccination to key target groups. Nonetheless, coverage among priority groups is low, and vaccine supplies vary widely across income levels. Continued investment in national programmes is needed, especially in middle-income CA to keep increasing coverage among high-risk groups. FUNDING: This work was supported by the Pandemic Influenza Preparedness Framework Partnership Contribution.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。